Staurosporine ≥98%

Supplier: MP BIOMEDICALS (FKA ICN BIOMED

Synonyms: (5S,6R,7R,9R)-6-Methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14-one, Antibiotic AM-2282

0219140080 0219140090 0219140091
IC19140080EA 277.57 USD
IC19140080 IC19140090 IC19140091
Staurosporine ≥98%
Staurosporine

Staurosporine is provided in a lyophilised form. It may be reconstituted by dissolving the lyophilized reagent in DMSO (5 mg/mL-clear, colorless solution), DMF, ethyl acetate (5 mg/mL-clear colorless solution) or methanol. Stock solutions should be further diluted with aqueous buffers just prior to use. Stability depends upon the quality of solvent used. The compound should be stored at -20 °C in the dark.


Potent inhibitor of phospholipid/calcium-dependent protein kinase. Inhibits the upregulation of VEGF expression in tumor cells.

Formula: C₂₈H₂₆N₄O₃
MDL Number: MFCD18252446
CAS Number: 62996-74-1

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR